CytomX Therapeutics, Inc. (CTMX) Earnings
NASDAQ·Healthcare·Biotechnology
$2.24
+4.11%
Mkt Cap $466.30M
EPS — Estimate vs Actual
Mkt Cap
$466.30M
P/E
476.70
Fwd P/E
—
P/S
13.12
Rev TTM
—
EPS TTM
-$0.36
NASDAQ·Healthcare·Biotechnology
$2.24
+4.11%
Mkt Cap $466.30M
Mkt Cap
$466.30M
P/E
476.70
Fwd P/E
—
P/S
13.12
Rev TTM
—
EPS TTM
-$0.36